Efficacy & Safety of Clindamycin Phosphase 1.2% and Tretinoin 0.025% Gel vs. Vehicle for the Treatment of Acne and Acne-Induced Post Inflammatory Hyperpigmentation in Patients With Skin of Color

NCT01111994 Phase 4 UNKNOWN

The purpose of this study is ascertain the efficacy and safety of Clindamycin Phosphate 1.2% and Tretinoin 0.025% in the treatment of Acne and Post Inflammatory Hyperpigmentation in patients with skin of color.

Details

Lead sponsor	Callender Center for Clinical Research
Phase	Phase 4
Status	UNKNOWN
Enrolment	30
Start date	2009-11
Completion	2010-04

Conditions

• Acne

Interventions

• Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel

Primary outcomes

• Improvement of acne and post inflammatory hyperpigmentation — 3 months

Countries

United States